Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grupo Farsiman operates as a leading pharmaceutical group in Honduras with over 50 years of experience. It manufactures its own pharmaceutical products and distributes both proprietary and international brands nationally and regionally. The company has a strong retail presence through Farmacia Simán stores and also exports to markets such as Bangladesh.
Its initial product line included five brands still sold today—Expecto Broncol Jarabe, Limonada Purgante, Ferro Hierro, Tusimín Jarabe, Fungifar líquido—and it now encompasses manufacturing (Laboratorios Farsimán), distribution/wholesale (Droguería Simán), and retail pharmacy chains (Farmacia Simán).
No clinical trial or drug development pipeline information was found; the company focuses on commercialized generic medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grupo Farsiman.